Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 04:00PM ET
1.09
Dollar change
-0.18
Percentage change
-14.17
%
Index- P/E- EPS (ttm)-4.14 Insider Own67.35% Shs Outstand37.16M Perf Week-19.85%
Market Cap42.64M Forward P/E- EPS next Y-0.87 Insider Trans0.00% Shs Float12.77M Perf Month-33.94%
Income-141.82M PEG- EPS next Q-0.19 Inst Own14.82% Short Float1.41% Perf Quarter-90.00%
Sales0.00M P/S- EPS this Y-1909.52% Inst Trans4.33% Short Ratio1.99 Perf Half Y-81.53%
Book/sh-5.20 P/B- EPS next Y77.11% ROA-1150.77% Short Interest0.18M Perf Year-86.74%
Cash/sh0.04 P/C27.33 EPS next 5Y- ROE-27.38% 52W Range1.25 - 17.17 Perf YTD-84.86%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-93.65% Beta0.40
Dividend TTM- Quick Ratio0.16 Sales past 5Y0.00% Gross Margin- 52W Low-12.80% ATR (14)0.27
Dividend Ex-Date- Current Ratio0.16 EPS Y/Y TTM-4975.41% Oper. Margin0.00% RSI (14)30.73 Volatility15.28% 15.64%
Employees10 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price6.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q-16223.20% Payout- Rel Volume0.95 Prev Close1.27
Sales Surprise- EPS Surprise-922.58% Sales Q/Q- EarningsMay 14 AMC Avg Volume90.54K Price1.09
SMA20-29.29% SMA50-62.65% SMA200-82.90% Trades Volume85,748 Change-14.17%
Date Action Analyst Rating Change Price Target Change
Aug-18-23Initiated H.C. Wainwright Buy $18
May-29-24 09:35AM
08:00AM
May-14-24 04:05PM
May-09-24 09:35AM
08:00AM
04:08PM Loading…
May-03-24 04:08PM
03:55PM
02:37PM
09:05AM
08:31AM
07:00AM
Mar-30-24 10:53PM
Mar-29-24 04:15PM
03:45PM
Mar-19-24 04:30PM
04:29PM Loading…
04:29PM
Jan-18-24 04:05PM
Dec-12-23 08:00AM
Nov-15-23 04:49AM
Nov-13-23 08:15AM
Oct-19-23 04:05PM
Aug-29-23 08:00AM
Aug-24-23 08:00AM
Aug-16-23 07:00AM
Jul-24-23 07:00AM
AEON Biopharma, Inc. is a biopharmaceutical company. It engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Strathspey Crown Holdings Grou10% OwnerAug 11 '23Sale10.007,380,39473,803,9402,031,773Aug 14 04:10 PM